DRC begins clinical trial of Tumaini vaccine against Ebola Bundibugyo strain

The DRC has initiated a clinical trial of the Tumaini vaccine candidate targeting the Bundibugyo Ebola strain, for which no approved vaccine exists. The WHO is supporting the effort, which involves multiple candidates. This marks a significant step in addressing a less common but deadly strain, though efficacy and deployment remain uncertain.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works